Wick, A., Kessler, T., Platten, M., Meisner, C., Bamberg, M., Herrlinger, U., Felsberg, J., Weyerbrock, A., Papsdorf, K., Steinbach, J. P., Sabel, M., Vesper, J., Debus, J., Meixensberger, J., Ketter, R., Hertler, C., Mayer-Steinacker, R., Weisang, S., Bölting, H., Reuss, D., Reifenberger, G., Sahm, F., von Deimling, A., Weller, M., & Wick, W. (2020). superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma. Neuro-oncology, 22(8), 1162–1172. http://access.bl.uk/ark:/81055/vdc_100116625180.0x000019